Weaver Consulting Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-160
Closed -$17K 340
2020
Q3
$17K Buy
+160
New +$16.7K 0.01% 434
2020
Q2
Sell
-404
Closed -$27K 955
2020
Q1
$27K Buy
+404
New +$25.1K 0.02% 288

Other funds holding DXCM

Weaver Consulting Group's DXCM Position: Q4 2020 in Review

Weaver Consulting Group sold out of DexCom (DXCM) in Q4 2020, closing a stake of 160 shares — an estimated $17K sold.

Weaver Consulting Group first reported a position in DXCM in Q1 2020 and held it in 2 quarters. The position peaked at $27K in Q1 2020. 732 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

  • Weaver Consulting Group reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 160 DexCom shares in Q4 2020, an estimated $17K.
  • Weaver Consulting Group first reported a position in DexCom in Q1 2020 and held it in 2 quarters.
  • Weaver Consulting Group's DexCom position peaked at $27K in Q1 2020.
  • 732 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.